Business
Sotera Health to Showcase Continued Revenue Growth and Strategic Value Creation at 44th Annual J.P. Morgan Healthcare Conference
CLEVELAND, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of
About this update from Sotera Health Company
[{"type":"text","content":"CLEVELAND, Jan. 12, 2026 (GLOBE NEWSWIRE) -- Sotera Health Company (“Sotera Health” or the “Company”) (Nasdaq: SHC), a leading global provider of mission-critical end-to-end sterilization solutions, lab testing and advisory services for the healthcare industry, is presenting today at the 44th Annual J.P. Morgan Healthcare Conference. During the presentation, Management will be providing an update on Sotera Health’s business. “Sotera Health continued its solid growth trajectory in 2025, with revenue expected to surpass $1.16 billion, an increase of at least 5.5% year over year, or 5.0% on a constant-currency basis,” said Chairman and Chief Executive Officer Michael B. Petras, Jr. “This marks over two decades of year-over-year revenue growth, reflecting the durability of our business model, the strength and consistency of our financial profile, and our continued commitment to serve our customers with excellence. We look forward to sharing our full-year results and 2026 outlook on February 24, 2026.” A live webcast of the presentation, along with accompanying materials, will be available on the Investor Relations section of the Company’s website at Presentation & Events | Sotera Health. A replay will be available within 48 hours following the presentation and will remain archived on the Company's website. Cautionary Note Regarding Forward-Looking StatementsUnless expressly indicated or the context requires otherwise, the terms “Sotera Health,” “Company,” “we,” “us,” and “our” in this release refer to Sotera Health Company, a Delaware corporation, and, where appropriate, its subsidiaries on a consolidated basis. This release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 and reflects management’s expectations about future events and the Company’s operating plans and performance and speak only as of the date hereof. Forward-looking statements present our current forecasts and estimates of future events. These statements do not strictly relate to historical or current results and can be identified by words such as “anticipate,” “appear,” “assume,” “believe,” “estimate,” “expect,” “forecast,” “intend,” “likely,” “may,” “plan,” “project,” “seek,” “should,” “strategy,” “will” and other terms of similar meaning or import in connection with any discussion of future operating, ...